
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Editor of Patient Care Online.
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
The latest Stress in America™ poll from the American Psychological Association shows many US adults have suffered negative mental and physical changes due to pandemic-related stress.
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
What do US adults think about the disruption COVID-19 has had on their lives? Do they see the pandemic improving in the coming months? A recent Gallup poll offers insight.
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Results from a head-to-head study show the investigational medication, tirzepatide, led to superior A1c and body weight reductions compared to semaglutide.
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, and more.
US confirmed cases of COVID-19 have surpassed 29 million; global cases have reached 117 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Recent research presented at AAAAI 2021 Virtual Annual Meeting suggests asthma is not an independent risk factor for severe COVID-19 or hospitalization.
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
A new study suggests that women who experience an accelerated accumulation of abdominal fat during menopause are at greater risk of heart disease, even if their weight stays steady.
More than half of adults with obesity who received once-weekly semaglutide lost 15% of body weight, according to the recently published STEP 1 study.
Global confirmed cases of COVID-19 have surpassed 115 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Which states have the highest vaccination rates? What about the lowest death rate? Results from a recent nationwide comparison on the safest states during COVID-19 shed light.
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
New real-world data from England suggests that the Oxford-AstraZeneca and Pfizer-BioNTech COVID-19 vaccines are highly effective in reducing infections among older patients.
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
Johnson & Johnson's COVID-19 vaccine is now the third vaccine to receive emergency use authorization in the US.
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
A new modeling study estimates that 64% of US COVID-19 hospitalizations were attributable to at least 1 of 4 pre-existing cardiometabolic conditions.
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
Results of a new study show that the Pfizer-BioNTech COVID-19 vaccine is 92% effective at preventing severe COVID-19 after 2 doses in over half a million study participants.
Listen to our newest podcast episode where the lead author of a recent meta-analysis shares his findings on the safety and efficacy of antidepressant medications to treat back and osteoarthritis pain.
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
The FDA announced today that Johnson & Johnson's single-dose COVID-19 vaccine was found to be safe and effective against the novel disease.
Get a first look at key 8 studies to be presented at the upcoming AAAAI 2021 virtual meeting starting this Friday, February 26, 2021.
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
US COVID-19 mortalities have surpassed 500 000. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
In a new survey of patients with severe asthma, COVID-19-related anxiety was found to be a potential risk factor for clinical worsening of disease and decline in quality of life.
US confirmed cases of COVID-19 have surpassed 28 million; global cases have reached 111 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.